(Q38842105)

28 October 2017

Pharmacokinetic and Pharmacodynamic Modeling of MOD-4023, a Long-Acting Human Growth Hormone, in Growth Hormone Deficiency Children (English)

1 reference

growth hormone deficiency

28 October 2017

1 reference

1 reference

1 reference

2

Ron G Rosenfeld

1 reference

28 October 2017

Dennis M Fisher

1

1 reference

28 October 2017

Michal Jaron-Mendelson

3

1 reference

28 October 2017

Leanne Amitzi

4

1 reference

28 October 2017

Ronit Koren

5

1 reference

28 October 2017

Gili Hart

6

1 reference

28 October 2017

11 April 2017

1 reference

28 October 2017

9

1 reference

inferred from page(s)

published in

Hormone Research

1 reference

28 October 2017

87

1 reference

28 October 2017

5

1 reference

28 October 2017

324-332

1 reference

MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults

28 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5637306

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5637306

Observations of nonadherence to recombinant human growth hormone therapy in clinical practice

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5637306

A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5637306

Long-Acting C-Terminal Peptide-Modified hGH (MOD-4023): Results of a Safety and Dose-Finding Study in GHD Children.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5637306

In Vitro and in Vivo Characterization of MOD-4023, a Long-Acting Carboxy-Terminal Peptide (CTP)-Modified Human Growth Hormone.

22 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5637306

Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations

22 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5637306

Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society

22 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28399519

12 December 2020

inferred from PubMed ID database lookup

A pharmacokinetic/pharmacodynamic model for recombinant human growth hormone effects on induction of insulin-like growth factor I in monkeys

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28399519

12 December 2020

inferred from PubMed ID database lookup

Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28399519

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1159/000470842

1 reference

28 October 2017

1 reference

28 October 2017

1 reference